{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Echinomycin",
  "nciThesaurus": {
    "casRegistry": "512-64-1",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A polypeptide quinoxaline antineoplastic antibiotic isolated from the bacterium Streptomyces echinatus.  Echinomycin intercalates into DNA at two locations simultaneously in a sequence-specific fashion, thereby inhibiting DNA replication and RNA synthesis.",
    "fdaUniiCode": "TG824J6RQT",
    "identifier": "C462",
    "preferredName": "Echinomycin",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C582"
    ],
    "synonyms": [
      "BRN 0078671",
      "Bis-Quinoline Analogue",
      "ECHINOMYCIN",
      "Echinomycin",
      "Echinomycin A",
      "Levomycin",
      "N,N'-(2,4,12,15,17,25-hexamethyl-11,24-bis(1-methylethyl)-27-(methylthio)-3,6,10,13,16,19,23,26-octaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo(12.12.3)nonacosane-7,20-diyl)bis(2-quinoxalinecarboxamide)",
      "Quinomycin A",
      "SK 302B"
    ]
  }
}